Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 29, Issue 4, 2002, Pages 368-373

  Zala, Carlos ^a   Salomon, Horacio ^a   Ochoa, Claudia ^a   Kijak, Gustavo ^a   Federico, Andrea ^a   Perez, Héctor ^a   Montaner, Julio S G ^a   Cahn, Pedro ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Hydroxyurea; Nevirapine; Primary HIV infection; Toxicity

Indexed keywords

DIDANOSINE; HYDROXYUREA; NEVIRAPINE; STAVUDINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALOPECIA; ANEMIA; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERAMYLASEMIA; LIPODYSTROPHY; LIVER TOXICITY; LYMPHOCYTE COUNT; MALE; MOUTH ULCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCORING SYSTEM; VIRUS LOAD; VIRUS REPLICATION;

EID: 0036535260     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200204010-00007     Document Type: Article

References (12)

1. Comparison of antiretroviral response with abacavir/combivir to indinavir/combivir in therapy-naïve adults at 48 weeks
2. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
3. Factors predictive of durable HIV suppression in randomized double-blind trial with nevirapine (NVP), zidovudine (ZDV), and lamivudine (3TC) in treatment-naïve patients with advanced AIDS
4. Hydroxyurea in combination regimens for the treatment of antiviral-naive HIV infected adults
5. A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study
6. The effects of hydroxyurea or placebo combined with efavirenz, didanosine, and stavudine in treatment naïve and experienced patients: Preliminary 24 weeks results from the 3D study
7. HIV suppression by early treatment with hydroxyurea, didanosine and protease inhibitor
8. The effect of combination antiretroviral therapy soon after human immunodeficiency type 1 infection on viral replication and antiviral immune responses
9. Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: Results of the ANRS 053 trial
10. A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus disease receiving chronic didanosine therapy
11. Randomized trial of continued indinavir (IDV)/AZT/3TC versus switch to IDV/ddI/d4T + hydroxyurea in patients with viral suppression
12. Screening for nucleoside-associated lactic acidosis